Biopheresis Overview

  • Founded
  • 2003
  • Status
  • Out of Business
  • Employees
  • 4
  • Latest Deal Type
  • Out of Business

Biopheresis General Information


Operator of a bio-medical company intended to develops immunological therapies for the treatment of cancer. The company's bio-medical processes uses a medical device, an immuno-affinity column that specifically removes inhibiting sTNFRs from patients' blood, enabling doctors to get technology that removes inhibiting sTNFRs, to allow the bodyÂs own TNF mediated immune response to attack and destroy tumors.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Drug Delivery
Primary Office
  • Im Neuenheimer Feld 515
  • 69120 Heidelberg
  • Germany
+49 06221 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biopheresis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jun-2013 00.000 Completed Out of Business
2. Grant 10-Nov-2006 00000 00.000 Completed Startup
1. Early Stage VC (Series A) 12-May-2005 $8.39M $8.39M Completed Startup
To view Biopheresis’s complete valuation and funding history, request access »

Biopheresis Executive Team (6)

Name Title Board Seat Contact Info
Peter Wiesner Ph.D Managing Director
Henry Edmunds Director, Research & Development
You’re viewing 2 of 6 executive team members. Get the full list »

Biopheresis Board Members (5)

Name Representing Role Since
Jeffrey Muir Self Board Member 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Biopheresis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial